Bacil Pharma's board approved the 39th AGM.

BP

Bacil Pharma Ltd524516 · Filed with the exchange

Key items include a boost in authorized share capital from ₹20 Cr to ₹70 Cr.

Leadership moves include Chaitali Shah's MD re-designation and several director regularizations, plus a new auditor.

No comments yet. Be the first.

More from Bacil Pharma Ltd

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.